Form 8-K - Current report:
SEC Accession No. 0001193125-24-278626
Filing Date
2024-12-13
Accepted
2024-12-13 16:35:00
Documents
13
Period of Report
2024-12-09
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d906701d8k.htm   iXBRL 8-K 27295
  Complete submission text file 0001193125-24-278626.txt   145995

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grtsq-20241209.xsd EX-101.SCH 2515
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtsq-20241209_lab.xml EX-101.LAB 17204
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtsq-20241209_pre.xml EX-101.PRE 10791
16 EXTRACTED XBRL INSTANCE DOCUMENT d906701d8k_htm.xml XML 3639
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 241548922
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)